Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,439 | 13,091 | 13,355 | 14,294 | 14,203 |
| TOTAL | $19,828 | $13,628 | $14,045 | $14,614 | $14,683 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 8 | 9 | 10 | 25 | 66 |
| TOTAL | $8 | $9 | $10 | $25 | $66 |
| Total Assets | $19,836 | $13,637 | $14,055 | $14,639 | $14,749 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 589 | 448 | 441 | 564 | 562 |
| TOTAL | $589 | $448 | $441 | $564 | $562 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $589 | $448 | $441 | $564 | $562 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,255 | 13,410 | 13,410 | 13,410 | 13,410 |
| Common Shares | 1,342 | 1,334 | 1,334 | 1,334 | 1,334 |
| Retained earnings | -547,636 | -547,144 | -546,702 | -546,224 | -546,092 |
| TOTAL | $19,247 | $13,189 | $13,614 | $14,075 | $14,187 |
| Total Liabilities And Equity | $19,836 | $13,637 | $14,055 | $14,639 | $14,749 |